NMT Medical/Integra Lifesciences
This article was originally published in The Gray Sheet
Executive Summary
NMT's divestiture of the Selector ultrasonic aspirator, Ruggles surgical instruments and cryosurgery product lines to Integra LifeSciences for $12 mil. will enable the firm to refocus on its core cardiovascular business, the firm announces March 21. The product lines generated 1999 revenues of approximately $12.1 mil. In connection with the acquisition, Integra will change the name of its neurosurgical device business from Integra NeuroCare to Integra NeuroSciences, expand its direct sales force focusing on neurotrauma and neurosurgery to 45 U.S. reps, and build sales forces in the U.K. and Ireland
You may also be interested in...
Integra Boosts Neurosurgery Business Through Arthrocare Distribution Deal
Integra Lifesciences' decision to market Arthrocare's Coblation surgical system for brain tumor removal procedures is a part of the firm's ongoing strategy to bolster its growing neurology business.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.